<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03317782</url>
  </required_header>
  <id_info>
    <org_study_id>2017-1072</org_study_id>
    <nct_id>NCT03317782</nct_id>
  </id_info>
  <brief_title>NoL Index Variations Before and After a Stellate Ganglion Block</brief_title>
  <official_title>Evaluation of NoL Index Variations After a Painful Stimulus Before and After a Stellate Ganglion Block in Patients With Upper Extremity Complex Regional Pain Syndrome: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maisonneuve-Rosemont Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maisonneuve-Rosemont Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate and compare the NoL index variations after a painful physiotherapy exercise in
      patients with upper limb CRPS, before and after a stellate ganglion block.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 23, 2017</start_date>
  <completion_date type="Actual">April 4, 2019</completion_date>
  <primary_completion_date type="Actual">December 18, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in NoL index from baseline</measure>
    <time_frame>20 minutes</time_frame>
    <description>• Change in the NoL index after a painful physiotherapy exercise in patients with upper limb CRPS 20 minutes after a stellate ganglion block, from baseline (before the stellate ganglion block)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in peak NoL index values before and after a stellate ganglion block</measure>
    <time_frame>20 minutes</time_frame>
    <description>Measure the change in peak NoL index (peak NoL index after a painful physiotherapy exercise before the stellate ganglion block minus the peak NoL index value after a painful physiotherapy exercise after the stellate ganglion block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in Numeric Rating Scale (NRS) pain intensity score (from 0-10) before and after a stellate ganglion block</measure>
    <time_frame>20 minutes</time_frame>
    <description>Measure the change in NRS pain intensity score after a painful physiotherapy exercise, before and 20 minutes after a stellate ganglion block.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation between change in NoL index and change in the Numeric Rating Scale (NRS) pain score (from 0-10) from baseline</measure>
    <time_frame>20 minutes</time_frame>
    <description>Correlate the NoL index variation (delta NoL) with the NRS pain score variation (delta NRS) painful physiotherapy exercise in patients with upper limb CRPS, before and 20 minutes after a stellate ganglion block.</description>
  </secondary_outcome>
  <enrollment type="Actual">20</enrollment>
  <condition>Chronic Pain Syndrome</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NoL index</intervention_name>
    <description>The NoL/PMD-200 (Medasense Biometrics Ltd, Ramat Yishai, Israel) is a multi-parameter index (0-100) that incorporates heart rate, heart rate variability (0.15-0.4 Hz band power), plethysmograph wave amplitude, skin conductance level, number of skin conductance fluctuations (NSCF), and their time derivatives9 using a non-linear regression technique. A higher index indicates higher nociception, and an index &lt;20 indicates adequate analgesia.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with upper extremity complex regional pain syndrome treated at the pain clinic of
        the Maisonneuve-Rosemont Hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of upper limb CRPS according to the Budapest criteria12, for more than 6
             months;

          -  Significant pain relief from stellate ganglion block;

          -  Undergoing physical therapy;

          -  18 years and older.

        Exclusion Criteria:

          -  Patients taking beta blockers

               -  Bilateral/generalized CRPS

               -  Patients needing sedation for the procedure

               -  Inability to understand a Numeric Pain rating Scale due to cognitive dysfunction
                  or linguistic barrier

               -  Movement disorder making a person unable to lie still for the duration of the
                  evaluation period.

               -  Patient refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Veronique Brulotte, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maisonneuve-Rosemont Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maisonneuve Rosemont Hospital</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>h1t2m4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>October 14, 2017</study_first_submitted>
  <study_first_submitted_qc>October 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2017</study_first_posted>
  <last_update_submitted>September 12, 2019</last_update_submitted>
  <last_update_submitted_qc>September 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maisonneuve-Rosemont Hospital</investigator_affiliation>
    <investigator_full_name>Veronique Brulotte</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

